Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,017.2
18.4 (0.61%)

 

  • STI Straits Times Index
    3,017.2
    18.4 (0.61%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,594.8
    -6.7 (-0.42%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,927.8
    -34.7 (-0.12%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,621.3
    38.2 (1.07%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,756.9
    233.6 (0.82%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,413.9
    -15.9 (-0.25%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 3,598.5M
  • Value: 1,474.1M
  • Rise: 161
  • Fall: 218
  • Unch: 400

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.047-0.002
Shen Yao0.005+0.001
AusGroup0.038-
Jiutian Chemical0.108-0.001
The Place Hldg0.086+0.016
MarcoPolo Marine0.021-0.002
MMP Resources^0.006+0.002
Blumont0.005-0.001
V2Y Corp0.068+0.004
ETC Singapore0.052+0.001

World Indices

World Indices
Name Last Change
Nasdaq 13,457.2 +260.1
HSI 29,927.8 -34.7
HSCEI 11,889.5 -59.9
Jakarta 6,413.9 -15.9
Nikkei 225 28,756.9 +233.6
SSE Comp 3,621.3 +38.2
Shanghai A 3,795.9 +40.1
Shanghai B 251.2 +0.8
KOSPI 3,160.8 +46.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ENOCHIAN BIOSCIENCES INC ENOCHIAN BIOSCIENCES INC
Updated on 20 Jan 2021 (End of trading day)
Last (USD): 3.320 Change: -0.060 High: 3.400 Remarks: -
Change (%): -1.78 Low: 3.230
Open 3.380 Yesterday's Close 3.38
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 58,395 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.24479 Trailing EPS (USD) e -0.20863 NAV (USD) b 3.5215
PE a - Trailing PE f - Price / NAV b 0.9428
Dividend (USD) d - Cash In Hand (USD) g 0.1279 Issued & Paid-up Shares c 46,637,000
Dividend Yield (%) d - Price / Cash In Hand g 25.958 Treasury Shares h -
Market Cap (M) 154.835 Enterprise Value (M) 156.461
Piotroski F Score 0 Exchange Code ENOB Par Value ( $ ) n.a.
52 Weeks Volatility (%) 67.27 Free Float (%) 28.1
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 25 Sep 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 10 Dec 2018.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ENOCHIAN BIOSCIENCES INC NASDAQ 154.835 - - 0.9428 -
Industry Biotechnology NASDAQ 3,234.335 504.882 - 7.7594 0.526
Local Peer AMGEN INC NASDAQ 146,916.169 18.735 19.983 13.4060 2.335
Local Peer GILEAD SCIENCES INC NASDAQ 85,227.505 15.824 67.214 4.8855 3.743
Local Peer VERTEX PHARMACEUTICAL NASDAQ 61,550.995 52.303 22.876 7.5676 -
Local Peer ILLUMINA INC NASDAQ 58,916.840 58.799 92.346 12.5355 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 57,863.446 27.348 18.334 5.7146 -
Local Peer MODERNA INC NASDAQ 49,519.149 - - 17.9430 -
Local Peer BIOGEN INC NASDAQ 41,591.227 7.063 8.183 3.8659 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 34,501.051 14.350 36.066 3.1152 -
Local Peer SEAGEN INC NASDAQ 34,402.385 - 72.824 15.2356 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 33,083.551 - - 7.7163 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 24,586.599 - - 22.6010 -
Local Peer EXACT SCIENCES CORP NASDAQ 23,913.341 - - 10.2320 -
Other Local Peers INCYTE CORPORATION (NASDAQ), 10X GENOMICS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), BIO-TECHNE CORP (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), NOVAVAX INC (NASDAQ), ACCELERON PHARMA (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), TG THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), SEER INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), ARVINAS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), INSMED INC (NASDAQ), FIBROGEN INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), XENCOR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALLOVIR INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), NANTKWEST INC (NASDAQ), VIELA BIO INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), PERSONALIS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), NKARTA INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), BIOATLA INC (NASDAQ), INHIBRX INC (NASDAQ), ALECTOR INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), CYTOKINETICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), VAXCYTE INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), OMEROS CORP (NASDAQ), EPIZYME INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), COMPUGEN (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), HUMANIGEN INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CORTEXYME INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), KADMON HLDGS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), AFFIMED N V (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), VAXART INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), IMMATICS N V (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), MERUS B V (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), ANAPTYSBIO INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), AGENUS INC (NASDAQ), ONCORUS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ARDELYX INC (NASDAQ), AKOUOS INC (NASDAQ), AVROBIO INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), BIOVIE INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), ATRECA INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), PROTHENA CORP PLC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), IVERIC BIO INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CHIMERIX INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), XOMA CORP (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), ATHERSYS INC (NASDAQ), INMUNE BIO INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CABALETTA BIO INC (NASDAQ), TREVENA INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), NEXTCURE INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), KAMADA LTD (NASDAQ), BELLUS HEALTH INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ADICET BIO INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), MEDICINOVA INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), IMV INC (NASDAQ), METACRINE INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CHIASMA INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), EVOGENE LTD (NASDAQ), AXCELLA HEALTH INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), SESEN BIO INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), IMMUNOME INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), INFLARX N V (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), SYNLOGIC INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), COHBAR INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BIOCARDIA INC (NASDAQ), ADVAXIS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), SOLIGENIX INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), PRECIPIO INC (NASDAQ), ATYR PHARMA INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), HISTOGEN INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), GEOVAX LABS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), SENESTECH INC (NASDAQ)
Global Peer CSL LTD ASX 122,287.912 38.991 38.991 12.8987 1.092
Global Peer WUXI BIO HKEx 468,000.104 407.103 325.021 31.3296 -
Global Peer BEIGENE HKEx 259,615.740 - - 7.8131 -
Global Peer SINO BIOPHARM HKEx 152,392.047 49.651 59.551 4.2282 0.658
Global Peer ZAI LAB-SB HKEx 132,388.397 - - 36.6973 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 5,717.013 104.899 34.316 4.5681 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 21,813.873 - - 2.9835 -
Global Peer ARCUS BIOSCIENCES INC NYSE 2,507.338 - - 4.6056 -
Global Peer 3SBIO HKEx 19,382.232 17.554 12.908 1.6570 -
Other Global Peers VIVA BIOTECH (HKEx), JACOBIO-B (HKEx), MYOVANT SCIENCES LTD (NYSE), ALPHAMAB-B (HKEx), JW THERAP-B (HKEx), ASCENTAGE-B (HKEx), FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), HAOHAI BIOTEC (HKEx), JHBP-B (HKEx), MESOBLAST LTD (ASX), TELIX PHARMACEUTIC (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), SQZ BIOTECHNOLOGIES CO (NYSE), KINTOR PHARMA-B (HKEx), DPHARMA (Bursa), SINOMAB BIO-B (HKEx), OPTHEA LIMITED (ASX), ASCLETIS-B (HKEx), LEE'S PHARM (HKEx), IMUGENE LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), ESSEX BIO-TECH (HKEx), 22ND CENTURY GROUP INC (NYSE American), IMMUTEP LTD (ASX), NANOVIRICIDES INC (NYSE American), NEXT SCIENCE LTD (ASX), ANTEOTECH LIMITED (ASX), ENZO BIOCHEM INC (NYSE), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), IBIO INC (NYSE American), CEL-SCI CORP (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), BIONOMICS LTD (ASX), AIM IMMUNOTECH INC (NYSE American), UNI-BIO GROUP (HKEx), LEAF RESOURCES LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), REGENT PACIFIC (HKEx), MEMPHASYS LTD (ASX), GENETIC TECHNOLOGIES (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), BIOTRON (ASX), ORAGENICS INC (NYSE American), CT ENTERPRISE (HKEx), PATRYS LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), Suntar Eco-City (SGX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), REGENEUS LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), AVECHO BIOTECHNOLOGY LTD (ASX), ADALTA LTD (ASX), RHINOMED LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), NANOLLOSE LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), CRYOSITE (ASX), HOLISTA COLLTECH LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.110
+3.43 %
10 Days -+0.190
+6.07 %
20 Days -+0.400
+13.70 %
Medium Term Return 3 Months -+0.020
+0.61 %
6 Months --0.750
-18.43 %
1 Year --2.090
-38.63 %
Long Term Return 2 Years --4.280
-56.32 %
Annualised Return Annualised --
-33.91 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.950 - 13.430 Change From 1 Year Low +1.370 % Change From 1 Year Low (%) +70.26
Change From 1 Year High -10.110 % Change From 1 Year High (%) -75.28
2 Years Range 1.950 - 13.430 Change From 2 Years Low +1.370 % Change From 2 Years Low (%) +70.26
Change From 2 Years High -10.110 % Change From 2 Years High (%) -75.28
5 Years Range 1.950 - 13.430 Change From 5 Years Low +1.370 % Change From 5 Years Low (%) +70.26
Change From 5 Years High -10.110 % Change From 5 Years High (%) -75.28
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Enochian Biosciences, Inc. engages in the development of genetically modified cellular and immune-therapy technologies for treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev on January 18, 2011 and is headquartered in Los Angeles, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
20 Jan 2021 3.380 3.400 3.230 3.320 58,395 -
19 Jan 2021 3.110 3.420 3.110 3.380 271,797 -
15 Jan 2021 3.200 3.263 3.085 3.090 130,941 -
14 Jan 2021 3.110 3.300 3.110 3.210 176,052 -
13 Jan 2021 3.230 3.380 3.020 3.020 173,890 -
12 Jan 2021 3.290 3.340 3.200 3.230 52,797 -
11 Jan 2021 3.200 3.330 3.140 3.240 151,968 -
08 Jan 2021 3.110 3.310 3.110 3.180 77,964 -
07 Jan 2021 3.230 3.430 3.010 3.130 204,388 -
06 Jan 2021 3.460 3.485 3.170 3.230 87,680 -
05 Jan 2021 3.190 3.620 3.190 3.460 242,691 -
04 Jan 2021 2.950 3.220 2.939 3.160 112,389 -
31 Dec 2020 3.190 3.190 2.950 2.950 87,001 -
30 Dec 2020 3.060 3.250 3.000 3.230 166,102 -
29 Dec 2020 3.000 3.030 2.925 3.020 124,185 -
28 Dec 2020 2.980 3.300 2.920 2.950 206,368 -
24 Dec 2020 2.970 3.020 2.890 2.920 43,800 -
23 Dec 2020 2.970 3.010 2.850 2.930 145,961 -
22 Dec 2020 3.050 3.570 2.820 2.870 425,252 -
21 Dec 2020 3.180 3.300 3.010 3.080 68,304 -
18 Dec 2020 3.140 3.570 2.800 3.330 506,442 -
17 Dec 2020 3.050 3.140 2.980 3.110 28,218 -
Summary
Current 2 Weeks
(06 Jan 2021 to 20 Jan 2021)
3.460 3.485 3.010 3.320 1,385,872 -
Previous 2 Weeks
(21 Dec 2020 to 05 Jan 2021)
3.180 3.485 3.010 3.460 1,622,053 -
4 Weeks from
(20 Nov 2020 to 18 Dec 2020)
3.180 3.485 3.010 3.330 1,709,215 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.